Iraq vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Iraq
100.0%
in 2021
Sur
82.0%
in 2024
Iraq rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Iraq
- Sur
How they compare
Iraq currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Iraq's figure about 1.2 times Sur's.
The two have swapped places 1 time across 5 shared years of data; in 2011 it was Sur ahead.
Iraq ranks 1st and Sur ranks 2nd of 144 countries.
Across the 2 decades both report, Iraq averaged higher in 1 and Sur in 1.
Head to head by decade
| Decade | Iraq | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.7% | 74.0% | 7.3% | Sur |
| 2020s | 100.0% | 76.0% | 24.0% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Iraq or Sur?
- Iraq, at 100.0% against 82.0% in Sur as of 2021.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Iraq and Sur?
- 18.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Sur?
- 5 years are reported by both, from 2011 to 2021.
- How do Iraq and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Iraq ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.